Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection
Daniel R. Goldstein, … , Shizuo Akira, Fadi G. Lakkis
Daniel R. Goldstein, … , Shizuo Akira, Fadi G. Lakkis
Published May 15, 2003
Citation Information: J Clin Invest. 2003;111(10):1571-1578. https://doi.org/10.1172/JCI17573.
View: Text | PDF
Article

Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection

  • Text
  • PDF
Abstract

The Toll-like receptors (TLRs) are recently discovered germline-encoded receptors on APCs that are critically important in innate immune recognition of microbial pathogens. However, their role in solid-organ transplantation is unknown. To explore this role, we employed a skin allograft model using mice with targeted deletion of the universal TLR signal adaptor protein, MyD88. We report that minor antigen–mismatched (HY-mismatched) allograft rejection cannot occur in the absence of MyD88 signaling. Furthermore, we show that the inability to reject these allografts results from a reduced number of mature DCs in draining lymph nodes, leading to impaired generation of anti–graft-reactive T cells and impaired Th1 immunity. Hence, this work demonstrates that TLRs can be activated in a transplant setting and not solely by infections. These results link innate immunity to the initiation of the adaptive alloimmune response.

Authors

Daniel R. Goldstein, Bethany M. Tesar, Shizuo Akira, Fadi G. Lakkis

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
MyD88–/– mice have impaired adaptive immune responses to HY antigens. HY...
MyD88–/– mice have impaired adaptive immune responses to HY antigens. HY-specific tetramers were used to quantify the number of anti-HY CD8+ T cells in response to full-thickness male allografts. Fourteen days after transplantation, spleen cells were harvested from MyD88+/+ and MyD88–/– females, and T cells were purified with magnetic microbeads, stained with KCSRNRQYL HY tetramer (HDb) conjugated to phycoerythrin and FITC-conjugated anti-CD8, and then analyzed by flow cytometry. (a) Representative flow cytometric plots of HY tetramer staining, showing base-line purified naive T cells in MyD88+/+ and MyD88–/– mice; and plots of spleen cells from MyD88+/+ and MyD88–/– recipients of MyD88+/+ and MyD88–/– skin grafts, respectively, 14 days after transplantation, demonstrating a reduced number of CD8+ tetramer-positive cells in MyD88–/– recipients. Positive control from an HY transgenic animal and specificity control using KAVYNFATC HDb tetramer are shown. (b) Histogram plot of pooled data from three experiments demonstrating that MyD88–/– mice manifested an impaired generation of anti-HY CD8+ T cells in response to transplantation, compared with WT mice (1.52% vs. 15.79%, P = 0.01).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts